Skip to main content
Richard Applegate, MD, Anesthesiology, Loma Linda, CA

RichardLApplegateMD

Anesthesiology Loma Linda, CA

Cardiothoracic Anesthesiology

Chair, Anesthesiology and Professor of the Floyd S. Brauer Endowed Chair in Anesthesia, Loma Linda University

Dr. Applegate is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Applegate's full profile

Already have an account?

  • Office

    11234 Anderson Street Room 2532
    Loma Linda, CA 92354
    Phone+1 909-558-4475

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Anesthesiology, 1985 - 1986
  • Loma Linda University Health Education Consortium
    Loma Linda University Health Education ConsortiumResidency, Anesthesiology, 1982 - 1985
  • Loma Linda University School of Medicine
    Loma Linda University School of MedicineClass of 1982

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1983 - 2025
  • MN State Medical License
    MN State Medical License 1985 - 1986
  • American Board of Anesthesiology Anesthesiology
  • National Board of EchocardiographyAdvanced Perioperative TEE

Awards, Honors, & Recognition

  • Top MD Consumers Checkbook

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Crotalus Atrox Venom Preconditioning Increases Plasma Fibrinogen and Reduces Perioperative Hemorrhage in a Rat Model of Surgical Brain Injury  
    Tim Lekic, Richard Applegate, Brian S Bull, Ronak Raval, Nature

Lectures

  • 2013 CSA Winter Hawaii Anesthesia Seminar 
    California Society of Anesthesiologists, Maui, Hawaii - 1/21/2013

Press Mentions

  • Masimo ORi(TM) Granted De Novo as the First and Only FDA-Cleared Noninvasive and Continuous Parameter to Provide Insight into Hyperoxia Under Supplemental Oxygen
    Masimo ORi(TM) Granted De Novo as the First and Only FDA-Cleared Noninvasive and Continuous Parameter to Provide Insight into Hyperoxia Under Supplemental OxygenOctober 14th, 2023

Professional Memberships